Evaluating ANI Pharmaceuticals: Insights From 5 Financial Analysts
ANI Pharmaceuticals (NASDAQ:ANIP) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below summarizes their recent ra
BenzingaApr 23 14:00 ET
Express News | Guggenheim Reiterates Buy on ANI Pharmaceuticals, Maintains $77 Price Target
Moomoo 24/7Apr 23 12:55 ET
ANI Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/23/2024 17.34% Guggenheim → $77 Reiterates Buy → Buy 03/15/2024 — Capital One Initiates Coverage On →
BenzingaApr 23 12:53 ET
ANI Pharmaceuticals(ANIP.US) Officer Sells US$1.77 Million in Common Stock
$ANI Pharmaceuticals(ANIP.US)$ Officer Shanmugam Muthusamy sold 27,232 shares of common stock on Apr 18, 19, 2024 at an average price of $65.1 for a total value of $1.77 million.Source: Announcement W
moomoo NewsApr 22 19:10 ET
Form 144 | ANI Pharmaceuticals(ANIP.US) Officer Proposes to Sell 1.1 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 19, $ANI Pharmaceuticals(ANIP.US)$ Officer Shanmugam Muthusamy intends to sell 16,809 shares of its common stock on Apr 19, with a total market value of approximately $1.1
moomoo NewsApr 19 16:47 ET
Form 144 | ANI Pharmaceuticals(ANIP.US) Officer Proposes to Sell 677.27K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 18, $ANI Pharmaceuticals(ANIP.US)$ Officer Shanmugam Muthusamy intends to sell 10,423 shares of its common stock on Apr 18, with a total market value of approximately $677.
moomoo NewsApr 18 16:53 ET
ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 A.m. ET
BAUDETTE, Minn., April 18, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (NASDAQ:ANIP) today announced that the Company will release its first quarter 2024 financial results on Friday, May
GlobeNewswireApr 18 16:05 ET
ANI Pharmaceuticals(ANIP.US) Officer Sells US$1.5 Million in Common Stock
$ANI Pharmaceuticals(ANIP.US)$ Officer Shanmugam Muthusamy sold 22,768 shares of common stock on Apr 15, 16, 17, 2024 at an average price of $65.91 for a total value of $1.5 million.Source: Announceme
moomoo NewsApr 17 17:14 ET
Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing
Muthusamy Shanmugam, Director & Head, Research & Development, and COO, Novitium Operations, on April 15, 2024, sold 22,768 shares in Ani Pharmaceuticals (ANIP) for $1,500,589. Following the Form 4 fil
MT NewswiresApr 17 16:36 ET
Form 144 | ANI Pharmaceuticals(ANIP.US) Officer Proposes to Sell 622.58K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 17, $ANI Pharmaceuticals(ANIP.US)$ Officer Shanmugam Muthusamy intends to sell 9,520 shares of its common stock on Apr 17, with a total market value of approximately $622.5
moomoo NewsApr 17 16:21 ET
ANI Pharmaceuticals Financial Report: Key Insights Revealed
TipRanksApr 17 08:12 ET
Form 144 | ANI Pharmaceuticals(ANIP.US) Officer Proposes to Sell 386.19K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 16, $ANI Pharmaceuticals(ANIP.US)$ Officer Shanmugam Muthusamy intends to sell 5,834 shares of its common stock on Apr 16, with a total market value of approximately $386.1
moomoo NewsApr 16 16:47 ET
Form 144 | ANI Pharmaceuticals(ANIP.US) Officer Proposes to Sell 491.76K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 15, $ANI Pharmaceuticals(ANIP.US)$ Officer Shanmugam Muthusamy intends to sell 7,414 shares of its common stock on Apr 15, with a total market value of approximately $491.7
moomoo NewsApr 15 21:35 ET
ANI Pharmaceuticals(ANIP.US) Officer Sells US$16,947.5 in Common Stock
$ANI Pharmaceuticals(ANIP.US)$ Officer Cook Meredith sold 250 shares of common stock on Apr 12, 2024 at an average price of $67.79 for a total value of $16,947.5.Source: Announcement What is statement
moomoo NewsApr 15 19:08 ET
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Is Favoured by Institutional Owners Who Hold 64% of the Company
Yahoo FinanceApr 12 07:40 ET
ANI Pharmaceuticals (ANIP) Stock Moves -0.13%: What You Should Know
Yahoo FinanceApr 10 18:15 ET
Moderna (MRNA) Up 6% on Upbeat Data From Cancer Jab Study
Yahoo FinanceApr 10 10:59 ET
Syros (SYRS) Up on FDA Fast Track Tag for Tamibarotene in AML
Yahoo FinanceApr 10 09:49 ET
Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
Yahoo FinanceApr 9 13:34 ET
Corcept (CORT) Completes Enrollment in Ovarian Cancer Study
Yahoo FinanceApr 9 11:09 ET
No Data
No Data